HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum 25-hydroxyvitamin D, transitions between frailty states, and mortality in older adults: the Invecchiare in Chianti Study.

AbstractOBJECTIVES:
To assess whether serum 25-hydroxyvitamin D (25(OH)D) concentrations relate to transitions between the states of robustness, prefrailty, and frailty and to mortality in older adults.
DESIGN:
The Invecchiare in Chianti (InCHIANTI) Study, a prospective cohort study.
SETTING:
Tuscany, Italy.
PARTICIPANTS:
Adults aged 65 and older (N = 1,155).
MEASUREMENTS:
Serum 25(OH)D concentrations measured at baseline; frailty state (robust, prefrail, frail) assessed at baseline and 3 and 6 years after enrollment; and vital status determined 3 and 6 years after enrollment.
RESULTS:
The median (interquartile range) 25(OH)D concentration was 16.0 ng/mL (10.4-25.6 ng/mL; multiply by 2.496 to convert to nmol/L). Prefrail participants with 25(OH)D levels less than 20 ng/mL were 8.9% (95% confidence interval (CI) = 2.5-15.2%) more likely to die, 3.0% (95% CI = -5.6-14.6%) more likely to become frail, and 7.7% (95% CI = -3.5-18.7%) less likely to become robust than prefrail participants with 25(OH)D levels of 20 ng/mL or more. In prefrail participants, each 5-ng/mL decrement of continuous 25(OH)D was associated with 1.46 times higher odds of dying (95% CI = 1.18-2.07) and 1.13 higher odds of incident frailty (95% CI = 0.90-1.39) than with recovery of robustness. Transitions from robustness or frailty were not associated with 25(OH)D levels.
CONCLUSION:
Results provide evidence that prefrailty is an "at risk" state from which older adults with high 25(OH)D levels are more likely to recover than to decline, but high 25(OH)D levels were not associated with recovery from frailty. Thus, 25(OH)D levels should be investigated as a potential therapy to treat prefrailty and prevent further decline.
AuthorsMichelle Shardell, Christopher D'Adamo, Dawn E Alley, Ram R Miller, Gregory E Hicks, Yuri Milaneschi, Richard D Semba, Antonio Cherubini, Stefania Bandinelli, Luigi Ferrucci
JournalJournal of the American Geriatrics Society (J Am Geriatr Soc) Vol. 60 Issue 2 Pg. 256-64 (Feb 2012) ISSN: 1532-5415 [Electronic] United States
PMID22283177 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Copyright© 2012, Copyright the Authors Journal compilation © 2012, The American Geriatrics Society.
Chemical References
  • Vitamin D
  • 25-hydroxyvitamin D
Topics
  • Aged
  • Disease Progression
  • Female
  • Frail Elderly
  • Geriatric Assessment
  • Humans
  • Male
  • Mortality
  • Prognosis
  • Prospective Studies
  • Vitamin D (analogs & derivatives, blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: